These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8666938)

  • 1. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype.
    Gumperz JE; Valiante NM; Parham P; Lanier LL; Tyan D
    J Exp Med; 1996 Apr; 183(4):1817-27. PubMed ID: 8666938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
    Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
    J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
    Vyas Y; Selvakumar A; Steffens U; Dupont B
    Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
    Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
    J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
    D'Andrea A; Chang C; Franz-Bacon K; McClanahan T; Phillips JH; Lanier LL
    J Immunol; 1995 Sep; 155(5):2306-10. PubMed ID: 7650366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
    Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
    Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
    Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
    J Exp Med; 1994 Aug; 180(2):537-43. PubMed ID: 8046332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.
    Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH
    J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
    Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
    Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells.
    Husain Z; Levitan E; Larsen CE; Mirza NM; Younes S; Yunis EJ; Alper CA; Dubey DP
    J Clin Immunol; 2002 Jan; 22(1):28-36. PubMed ID: 11958591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells.
    Münz C; Holmes N; King A; Loke YW; Colonna M; Schild H; Rammensee HG
    J Exp Med; 1997 Feb; 185(3):385-91. PubMed ID: 9053439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.
    Becker S; Tonn T; Füssel T; Uhrberg M; Bogdanow M; Seifried E; Seidl C
    Hum Immunol; 2003 Feb; 64(2):183-93. PubMed ID: 12559621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic Hh genes in the HLA-B(C) region control natural killer cell frequency and activity.
    Dubey DP; Alper CA; Mirza NM; Awdeh Z; Yunis EJ
    J Exp Med; 1994 Apr; 179(4):1193-203. PubMed ID: 8145038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
    McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
    Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection.
    Mele D; Pasi A; Cacciatore R; Mantovani S; Oliviero B; Mondelli MU; Varchetta S
    Liver Int; 2019 Jul; 39(7):1237-1245. PubMed ID: 31177636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell-mediated lysis of autologous cells modified by gene therapy.
    Liberatore C; Capanni M; Albi N; Volpi I; Urbani E; Ruggeri L; Mencarelli A; Grignani F; Velardi A
    J Exp Med; 1999 Jun; 189(12):1855-62. PubMed ID: 10377181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
    Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
    Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.